The economic impact associated with cerebrovascular events related to non-valvular atrial fibrillation (NVAF) in Italy: the role of apixaban. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 15, n. 1S, p. 3–4, 2014. DOI: 10.7175/fe.v15i1s.972. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/972. Acesso em: 29 oct. 2025.